{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:52:44Z","timestamp":1792623164096,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejim.2020.10.020","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T07:14:08Z","timestamp":1604387648000},"page":"34-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5930-7304","authenticated-orcid":false,"given":"Marcello","family":"Di Nisio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Potere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9673-4073","authenticated-orcid":false,"given":"Matteo","family":"Candeloro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Spacone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Pieramati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Ferrandu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"La Vella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Di Carlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Cibelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giustino","family":"Parruti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"Porreca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2020.10.020_bib0001","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","article-title":"Coagulation abnormalities and thrombosis in patients with COVID-19","volume":"7","author":"Levi","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.ejim.2020.10.020_bib0002","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2020.10.020_bib0003","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s13054-020-03022-1","article-title":"Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis","volume":"24","author":"Potere","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.ejim.2020.10.020_bib0004","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.thromres.2020.04.041","article-title":"Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejim.2020.10.020_bib0005","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2020.10.020_bib0006","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2020.10.020_bib0007","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2020.10.020_bib0008","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25948","article-title":"Elevated interleukin\u20106 and severe COVID\u201019: a meta\u2010analysis","author":"Aziz","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.ejim.2020.10.020_bib0009","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1161\/01.CIR.0000131660.51520.9A","article-title":"Bidirectional relation between inflammation and coagulation","volume":"109","author":"Levi","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2020.10.020_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102568","article-title":"Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy","volume":"19","author":"Toniati","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ejim.2020.10.020_bib0011","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.medmal.2020.05.001","article-title":"Tocilizumab therapy reduced intensive care unit admissions and\/or mortality in COVID-19 patients","volume":"50","author":"Klopfenstein","year":"2020","journal-title":"M\u00e9d Mal Infect"},{"key":"10.1016\/j.ejim.2020.10.020_bib0012","unstructured":"Sciascia, S., Apr\u00e0, F., Baffa, A., Baldovino, S., Boaro, D., Boero, R., et\u00a0al. Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19. Clin Exp Rheumatol n.d.;38:529\u201332."},{"key":"10.1016\/j.ejim.2020.10.020_bib0013","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ejim.2020.10.020_bib0014","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/jmv.25801","article-title":"Tocilizumab treatment in COVID\u201019: a single center experience","volume":"92","author":"Luo","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.ejim.2020.10.020_bib0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejim.2020.05.009","article-title":"Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia","volume":"76","author":"Capra","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2020.10.020_bib0016","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejim.2020.05.021","article-title":"Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study","volume":"76","author":"Campochiaro","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2020.10.020_bib0017","unstructured":"World Health Organization 2020. Clinical management of COVID-19 2020. https:\/\/www.who.int\/publications\/i\/item\/clinical-management-of-covid-19."},{"key":"10.1016\/j.ejim.2020.10.020_bib0018","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jaci.2020.04.027","article-title":"Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19","volume":"146","author":"Yang","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ejim.2020.10.020_bib0019","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jinf.2020.03.004","article-title":"Clinical progression of patients with COVID-19 in Shanghai, China","volume":"80","author":"Chen","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.ejim.2020.10.020_bib0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejim.2020.05.011","article-title":"Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy","volume":"76","author":"Morena","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2020.10.020_bib0021","article-title":"Tocilizumab for treatment of mechanically ventilated patients with COVID-19","author":"Somers","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2020.10.020_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104444","article-title":"Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: results from a single Italian Centre study on tocilizumab versus standard of care","volume":"129","author":"Quartuccio","year":"2020","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ejim.2020.10.020_bib0023","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3390\/microorganisms8050695","article-title":"Tocilizumab for treatment of severe COVID-19 patients: preliminary results from SMAtteo COvid19 REgistry (SMACORE)","volume":"8","author":"Colaneri","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.ejim.2020.10.020_bib0024","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1016\/S2665-9913(20)30173-9","article-title":"Tocilizumab in patients with severe COVID-19: a retrospective cohort study","volume":"2","author":"Guaraldi","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.ejim.2020.10.020_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/S2665-9913(20)30277-0","article-title":"Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study","author":"Biran","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.ejim.2020.10.020_bib0026","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1186\/s13054-020-03224-7","article-title":"Efficacy of tocilizumab treatment in severely ill COVID-19 patients","volume":"24","author":"Zhao","year":"2020","journal-title":"Crit Care"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620520304064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620520304064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:33:15Z","timestamp":1760607195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620520304064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":26,"alternative-id":["S0953620520304064"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2020.10.020","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2020.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}